Payment overview · 2025
General Payments
$40,989.04
166 reported records · 22 companies
Healthcare provider profile · identity verified
Kyle Reynolds, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · WASHINGTON, DC · NPI 1417334525
Verified facts
What the public records show
CMS Open Payments records show Kyle Reynolds, M.D. received $40,989.04 in general payments during 2025 across 166 reported records.
Stryker Corporation accounted for 43.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 51 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $17,925.29 | 43.7% | 30 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $12,295.91 | 30.0% | 49 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $3,489.19 | 8.5% | 19 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $3,106.74 | 7.6% | 14 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $1,610.48 | 3.9% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $671.52 | 1.6% | 17 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $368.09 | 0.9% | 1 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $334.09 | 0.8% | 4 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $295.83 | 0.7% | 4 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $224.31 | 0.6% | 5 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $216.69 | 0.5% | 5 | 2025 |
| Nipro Medical Corporation | Unresolved — no canonical attribution shown | $83.43 | 0.2% | 1 | 2025 |
| PolyMedics Innovations Inc. | Unresolved — no canonical attribution shown | $69.12 | 0.2% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $50.00 | 0.1% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $50.00 | 0.1% | 1 | 2025 |
| CashFlow Solutions, LLC | Unresolved — no canonical attribution shown | $46.60 | 0.1% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $41.14 | 0.1% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $28.21 | 0.1% | 2 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $27.08 | 0.1% | 1 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $25.03 | 0.1% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $24.58 | 0.1% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $5.71 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $26,396.25 | 10 |
| Food and Beverage | $7,161.78 | 142 |
| Travel and Lodging | $6,181.01 | 12 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250.00 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $16,557.47 | 12 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $16,193.79 | 11 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $9,840.65 | 12 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $3,106.74 | 14 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $1,986.34 | 21 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $1,200.00 | 1 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $1,200.00 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $854.44 | 11 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $497.98 | 15 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $483.30 | 9 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $334.09 | 4 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $241.52 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $201.73 | 2 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $175.12 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $172.29 | 1 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $168.96 | 1 | 2025 |
Source payment records
|
|||||
| OPTIS Normalized: optis |
Device | Abbott Laboratories | $158.21 | 1 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $154.96 | 8 | 2025 |
Source payment records
|
|||||
| IGT Devices Systems Undivided Normalized: igt devices systems undivided |
Device | Philips North America LLC | $147.11 | 2 | 2025 |
Source payment records
|
|||||
| Clinical Trial Product Normalized: clinical trial product |
Device | Boston Scientific Corporation | $137.01 | 1 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $133.17 | 3 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $120.71 | 3 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $117.01 | 2 | 2025 |
Source payment records
|
|||||
| BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION Normalized: blueprint patient specific instrumentation |
Device | Stryker Corporation | $93.88 | 1 | 2025 |
Source payment records
|
|||||
| Makoto Normalized: makoto |
Device | Nipro Medical Corporation | $83.43 | 1 | 2025 |
Source payment records
|
|||||
| Peripheral Vascular Undivided Normalized: peripheral vascular undivided |
Device | Philips North America LLC | $77.20 | 3 | 2025 |
Source payment records
|
|||||
| General - Thrombectomy Normalized: general thrombectomy |
Device | Boston Scientific Corporation | $69.23 | 4 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $54.25 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $50.00 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $50.00 | 1 | 2025 |
Source payment records
|
|||||
| LYMPHA PRESS OPTIMAL PLUS(US) BT Normalized: lympha press optimal plus us bt |
Device | CashFlow Solutions, LLC | $46.60 | 2 | 2025 |
Source payment records
|
|||||
| PCD-51 731A (US) - White Normalized: pcd 51 731a us white |
Device | CashFlow Solutions, LLC | $46.60 | 2 | 2025 |
Source payment records
|
|||||
| PCD-52 737A (US) White Normalized: pcd 52 737a us white |
Device | CashFlow Solutions, LLC | $46.60 | 2 | 2025 |
Source payment records
|
|||||
| SEISMIQ LITHOTRIP_PI Normalized: seismiq lithotrip pi |
Device | Boston Scientific Corporation | $44.01 | 4 | 2025 |
Source payment records
|
|||||
| ALPHAVAC Normalized: alphavac |
Device | AngioDynamics, Inc. | $41.14 | 1 | 2025 |
Source payment records
|
|||||
| Distaflo Bypass Grafts Normalized: distaflo bypass grafts |
Device | Bard Peripheral Vascular, Inc. | $38.43 | 1 | 2025 |
Source payment records
|
|||||
| INTHRILL THROMBECTOMY CATHETER Normalized: inthrill thrombectomy catheter |
Device | Stryker Corporation | $32.41 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $28.21 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $28.21 | 2 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $27.08 | 1 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $27.08 | 1 | 2025 |
Source payment records
|
|||||
| General - Atherectomy Normalized: general atherectomy |
Device | Boston Scientific Corporation | $27.06 | 1 | 2025 |
Source payment records
|
|||||
| COOK CELECT Normalized: cook celect |
Device | Cook Medical LLC | $26.73 | 2 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $26.66 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis Normalized: gore viabahn endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $25.03 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $24.58 | 1 | 2025 |
Source payment records
|
|||||
| REVCORE THROMBECTOMY CATHETER Normalized: revcore thrombectomy catheter |
Device | Stryker Corporation | $19.81 | 1 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $17.67 | 2 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $17.15 | 1 | 2025 |
Source payment records
|
|||||
| DIAMONDBACK PERIPHERAL Normalized: diamondback peripheral |
Device | Abbott Laboratories | $15.33 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $14.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 26 | 13 |
| Eliquis | Apixaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $40,989.04 · 166 records | Stryker Corporation | AFX2 Bifurcated Endograft System, ALPHAVAC, ARTIX MT, Alto Abdominal Stent Graft System, BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION, CGuard Prime Carotid Stent System, CLOTTRIEVER BOLD CATHETER, COOK CELECT, CT THROMBECTOMY SYSTEM KIT, Clinical Trial Product, DIAMONDBACK PERIPHERAL, Distaflo Bypass Grafts, ELUVIA, ENDOCROSS Device, ENROUTE Transcarotid Neuroprotection System, ESPRIT, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, Flexitouch Plus, GORE VIABAHN Endoprosthesis, General - Atherectomy, General - Therapies, General - Thrombectomy, General - Vascular Intervention, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, IGT Devices Systems Undivided, INTHRILL THROMBECTOMY CATHETER, Kerecis GraftGuide, Kerecis SurgiClose, LIMFLOW SYSTEM, LUTONIX Drug Coated Balloon, LYMPHA PRESS OPTIMAL PLUS(US) BT, LifeVest, Makoto, Nimbl, OPTIS, PCD-51 731A (US) - White, PCD-52 737A (US) White, Peripheral Vascular Undivided, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, REVCORE THROMBECTOMY CATHETER, Ranger, RotarexS 6 F x 135 cm, SEISMIQ LITHOTRIP_PI, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TREO ABDOMINAL STENT-GRAFT SYSTEM, Torus Stent Graft System, Varithena Administration Pack, Wegovy, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error